Liminatus Pharma LIMN
NASDAQ LIMN
$3.90 +0.15 (+4.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Liminatus Pharma (LIMN) Other Non Operating Income (2025 - 2026)

Updated

Liminatus Pharma's Other Non Operating Income came in at $29,245 for Q2 2026, down 75.0% from $116,894 a year earlier but up 600.0% from the prior quarter.

Analysis

Liminatus Pharma (LIMN) Other Non Operating Income (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Liminatus Pharma reported Other Non Operating Income of -$137,783; for FY2025, it was -$54,312.

  • The five-year range for quarterly Other Non Operating Income is -$94,335 (Q4 2025) to $116,894 (Q2 2025).
  • Business Quant data shows LIMN's Other Non Operating Income at $4,178 (Q1 2026), -$94,335 (Q4 2025) and -$76,871 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Liminatus Pharma 4.24 Mn 4.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29,245.00
Mar 31, 2026 4,178.00
Dec 31, 2025 -94,335.00
Sep 30, 2025 -76,871.00
Jun 30, 2025 116,894.00
API Access

Liminatus Pharma Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=LIMN&period=max&api_key=YOUR_API_KEY